Well out of my expertise I'm afraid, CP. I was surprised to hear Gary say the FDA only required 12 patients for our Ph2, but SNT went that bit extra with 15, so not really sure what to expect when they speak to the FDA to design the Ph3, following the Ph2 results. I'm sure it will require a larger patient pool, but just how large I don't know.
- Forums
- ASX - By Stock
- SNT
- SNT - General Discussions
SNT - General Discussions, page-110
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
|
|||||
Last
3.2¢ |
Change
0.001(3.23%) |
Mkt cap ! $41.29M |
Open | High | Low | Value | Volume |
3.1¢ | 3.2¢ | 3.1¢ | $8.331K | 268.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 300000 | 3.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.2¢ | 488373 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 300000 | 0.031 |
2 | 341985 | 0.030 |
7 | 1377931 | 0.029 |
4 | 797857 | 0.028 |
1 | 75000 | 0.027 |
Price($) | Vol. | No. |
---|---|---|
0.032 | 488373 | 3 |
0.033 | 665000 | 1 |
0.034 | 840000 | 2 |
0.036 | 343537 | 2 |
0.039 | 16000 | 1 |
Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |